Literature DB >> 32862740

The intrauterine perfusion of granulocyte-colony stimulating factor (G-CSF) before frozen-thawed embryo transfer in patients with two or more implantation failures.

Pinxiu Huang1,2,3, Chunling Yao1,2,3, Lihong Wei1,2,3, Zhong Lin4.   

Abstract

The objective of this study was to investigate the clinical benefits of intrauterine perfusion with G-CSF in patients undergoing a frozen-thawed embryo transfer (FET) after at least two previous implantation failures. This was a prospective, randomized, single-blind study. The intervention group received an intrauterine infusion of G-CSF whereas the placebo group was given an intrauterine infusion of physiological saline before embryo transfer. A third (control) group did not receive an intrauterine infusion prior to embryo transfer. The clinical pregnancy rates of both the intervention and placebo group were significantly higher than that in the control group (p < 0.05). But the miscarriage rates of the G-CSF were significantly lower than those of the other two groups (p < 0.05). The intrauterine infusion of G-CSF before frozen-thawed embryo transfer significantly reduced miscarriage rates and improve the live birth rates. While intrauterine perfusion with physiological saline did not reduce miscarriage rates.

Entities:  

Keywords:  G-GSF; IVF; intrauterine infusion; repeated implantation failure

Year:  2020        PMID: 32862740     DOI: 10.1080/14647273.2020.1811904

Source DB:  PubMed          Journal:  Hum Fertil (Camb)        ISSN: 1464-7273            Impact factor:   2.767


  1 in total

1.  What is the impact of granulocyte colony-stimulating factor (G-CSF) in subcutaneous injection or intrauterine infusion and during both the fresh and frozen embryo transfer cycles on recurrent implantation failure: a systematic review and meta-analysis?

Authors:  Zhijin Hou; Fangjie Jiang; Jie Yang; Yang Liu; Hao Zha; Xiaoling Yang; Jia Bie; Yushi Meng
Journal:  Reprod Biol Endocrinol       Date:  2021-08-13       Impact factor: 5.211

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.